First anti-BCMA therapy to be approved anywhere in the world

Study co-led by UCL and the London School of Hygiene & Tropical Medicine

Allergy drug approved for severe chronic rhinosinusitis with nasal polyps

Scientists from the University of Oxford say the drug is being ‘discarded prematurely’

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Creative chemists employ enzymes to build a complex but promising natural anti-cancer agent called cepafungin I in a […]